Literature DB >> 24012421

The TACI receptor regulates T-cell-independent marginal zone B cell responses through innate activation-induced cell death.

William A Figgett1, Kirsten Fairfax, Fabien B Vincent, Mélanie A Le Page, Indzi Katik, Devy Deliyanti, Pin Shie Quah, Pali Verma, Raelene Grumont, Steve Gerondakis, Paul Hertzog, Lorraine A O'Reilly, Andreas Strasser, Fabienne Mackay.   

Abstract

Activation-induced cell death (AICD) plays a critical role in immune homeostasis and tolerance. In T-cell-dependent humoral responses, AICD of B cells is initiated by Fas ligand (FasL) on T cells, stimulating the Fas receptor on B cells. In contrast, T-cell-independent B cell responses involve innate-type B lymphocytes, such as marginal zone (MZ) B cells, and little is known about the mechanisms that control AICD during innate B cell responses to Toll-like receptor (TLR) activation. Here, we show that MZ B cells undergo AICD in response to TLR4 activation in vivo. The transmembrane activator, calcium modulator, and cyclophilin ligand interactor (TACI) receptor and TLR4 cooperate to upregulate expression of both FasL and Fas on MZ B cells and also to repress inhibitors of Fas-induced apoptosis signaling. These findings demonstrate an unappreciated role for TACI and its ligands in the regulation of AICD during T-cell-independent B cell responses.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24012421     DOI: 10.1016/j.immuni.2013.05.019

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  26 in total

Review 1.  Toll-like receptors and B cells: functions and mechanisms.

Authors:  Claire M Buchta; Gail A Bishop
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

Review 2.  The BAFF/APRIL system in SLE pathogenesis.

Authors:  Fabien B Vincent; Eric F Morand; Pascal Schneider; Fabienne Mackay
Journal:  Nat Rev Rheumatol       Date:  2014-03-11       Impact factor: 20.543

3.  Neutrophils license iNKT cells to regulate self-reactive mouse B cell responses.

Authors:  Thomas Hägglöf; Saikiran K Sedimbi; Jennifer L Yates; Roham Parsa; Briana Hauff Salas; Robert A Harris; Elizabeth A Leadbetter; Mikael C I Karlsson
Journal:  Nat Immunol       Date:  2016-10-31       Impact factor: 25.606

4.  The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity.

Authors:  Franziska S Hoffmann; Peer-Hendrik Kuhn; Sarah A Laurent; Stefanie M Hauck; Kerstin Berer; Simone A Wendlinger; Markus Krumbholz; Mohsen Khademi; Tomas Olsson; Martin Dreyling; Hans-Walter Pfister; Tobias Alexander; Falk Hiepe; Tania Kümpfel; Howard C Crawford; Hartmut Wekerle; Reinhard Hohlfeld; Stefan F Lichtenthaler; Edgar Meinl
Journal:  J Immunol       Date:  2014-12-10       Impact factor: 5.422

5.  Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.

Authors:  Sonia Schuepbach-Mallepell; Dolon Das; Laure Willen; Michele Vigolo; Aubry Tardivel; Luc Lebon; Christine Kowalczyk-Quintas; Josquin Nys; Cristian Smulski; Timothy S Zheng; Klaus Maskos; Alfred Lammens; Xuliang Jiang; Henry Hess; Seng-Lai Tan; Pascal Schneider
Journal:  J Biol Chem       Date:  2015-05-07       Impact factor: 5.157

Review 6.  Belimumab in systemic lupus erythematosus: a perspective review.

Authors:  Joyce S Hui-Yuen; Xiao Q Li; Anca D Askanase
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-08       Impact factor: 5.346

7.  Antibodies That Block or Activate Mouse B Cell Activating Factor of the Tumor Necrosis Factor (TNF) Family (BAFF), Respectively, Induce B Cell Depletion or B Cell Hyperplasia.

Authors:  Christine Kowalczyk-Quintas; Sonia Schuepbach-Mallepell; Michele Vigolo; Laure Willen; Aubry Tardivel; Cristian R Smulski; Timothy S Zheng; Jennifer Gommerman; Henry Hess; Jacques-Eric Gottenberg; Fabienne Mackay; Olivier Donzé; Pascal Schneider
Journal:  J Biol Chem       Date:  2016-07-22       Impact factor: 5.157

8.  Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis.

Authors:  Fabiana Rizzo; Elena Giacomini; Rosella Mechelli; Maria Chiara Buscarinu; Marco Salvetti; Martina Severa; Eliana Marina Coccia
Journal:  Immunol Cell Biol       Date:  2016-06-06       Impact factor: 5.126

9.  Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells.

Authors:  Samuel W Du; Holly M Jacobs; Tanvi Arkatkar; David J Rawlings; Shaun W Jackson
Journal:  J Immunol       Date:  2018-10-29       Impact factor: 5.422

10.  Belimumab promotes negative selection of activated autoreactive B cells in systemic lupus erythematosus patients.

Authors:  Weiqing Huang; Tam D Quach; Cosmin Dascalu; Zheng Liu; Tungming Leung; Miranda Byrne-Steele; Wenjing Pan; Qunying Yang; Jian Han; Martin Lesser; Thomas L Rothstein; Richard Furie; Meggan Mackay; Cynthia Aranow; Anne Davidson
Journal:  JCI Insight       Date:  2018-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.